Author: Terai K Sakamoto K Goto M Matsuda M Kasamaki S Shinmura K Takita N Kamano T
Publisher: Field House Publishing
ISSN: 0300-0605
Source: The Journal of International Medical Research, Vol.34, Iss.4, 2006-08, pp. : 385-389
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Hussein Abd El-Aziz M. Omar Nisereen M. Sakr Hussein Elsamanoudy Ayman Z. Shaheen Dalia
Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 3, 2011-03 ,pp. :
Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :
Drugs in Clinical Development for Type 2 Diabetes Mellitus: Summary and Table
Pharmaceutical Medicine, Vol. 26, Iss. 1, 2012-02 ,pp. :
Linagliptin: In Type 2 Diabetes Mellitus
Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. :